Bringing Critical aMPV Vaccines to the U.S. Poultry Industry

584

Avian metapneumovirus (aMPV) continues to be a significant respiratory challenge for poultry producers, particularly during peak risk periods. In this episode of the Poultry Producer Podcast, we explore the introduction of two proven aMPV vaccines now entering the U.S. market.

Joined by Scott Gustin, Poultry Technical Lead at Elanco, and Martina Dardi, the conversation takes a practical look at what aMPV is, why it remains difficult to manage, and how these newly introduced vaccines are helping strengthen flock health. The discussion covers vaccine development, collaboration between Elanco and HIPRA, early field observations, and what success looks like as producers and veterinarians evaluate these new tools.

Whether you’re a producer, veterinarian, or integrator, this episode offers timely insight into aMPV control strategies and what’s next for respiratory disease prevention in poultry operations.

Elanco US Inc. has been issued an import permit for the importation of HIPRAVIAR® TRT and RESPIVAC® aMPV for vaccination of US flocks.
 
FOR VETERINARY USE ONLY.
HIPRAVIAR® TRT and RESPIVAC® aMPV are trademarks of Laboratorios Hipra, S.A.
Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.
© 2026 Elanco or its affiliates. PM-US-25-2072